Related Experiment Video

Updated: Aug 17, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

An adaptive group sequential design for phase II/III clinical trials that select a single treatment from several

Patrick J Kelly1, Nigel Stallard, Susan Todd

  • 1Medical and Pharmaceutical Statistics Research Unit, The University of Reading, UK. patrick.kelly@reading.ac.uk

Journal of Biopharmaceutical Statistics
|July 19, 2005
PubMed

Insights

This study introduces a flexible adaptive trial design for efficiently selecting the best experimental treatment by dropping less promising options early. This method ensures valid comparisons with control treatments across various outcome types.

Area of Science:

  • Clinical trial methodology
  • Biostatistics
  • Drug development

Background:

  • Increasing interest in integrating Phase II and III clinical trials.
  • Need for efficient methods to select superior experimental treatments early.
  • Requirement for valid comparisons between selected treatments and controls.

Purpose of the Study:

  • To present a flexible adaptive group sequential design for multi-stage clinical trials.
  • To enable the selection of one experimental treatment from multiple candidates.
  • To ensure valid comparisons with a control treatment throughout the trial.

Main Methods:

  • Utilizes adaptive group sequential methodology to monitor an order statistic.
  • Employs efficient scores for the test statistic, allowing application to diverse outcome types.
  • Design accommodates variable stages, initial number of treatments, and ongoing treatment selection.

Main Results:

  • The proposed design is highly flexible regarding trial stages and treatment numbers.
  • The method is applicable to binary, ordinal, failure time, and normally distributed outcomes.
  • Simulations confirm the design's control of type I error rate and power across scenarios.

Conclusions:

  • The presented adaptive design offers a robust and flexible approach for combined Phase II/III clinical trials.
  • This methodology facilitates efficient selection of promising treatments while maintaining statistical validity.
  • The design's adaptability and broad applicability to different outcome measures enhance its utility in drug development.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...